Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause

Sinus tumors are arduous to diagnose due to often prolonging asymptomatic course until the infiltration of the adjacent structures occurs. Therefore, patients are diagnosed with advanced-stage disease, which negatively affects the treatment outcomes. A 60-year-old male was referred to our ward from...

Full description

Bibliographic Details
Main Authors: Olga Lesniewska-Skowerska, Joanna Symela-Kaspera, Lucyna Klimczak-Gołąb, Wojciech Smolka, Jaroslaw Markowski
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Hematology Reports
Subjects:
Online Access:https://www.mdpi.com/2038-8330/14/4/44
_version_ 1827638539816271872
author Olga Lesniewska-Skowerska
Joanna Symela-Kaspera
Lucyna Klimczak-Gołąb
Wojciech Smolka
Jaroslaw Markowski
author_facet Olga Lesniewska-Skowerska
Joanna Symela-Kaspera
Lucyna Klimczak-Gołąb
Wojciech Smolka
Jaroslaw Markowski
author_sort Olga Lesniewska-Skowerska
collection DOAJ
description Sinus tumors are arduous to diagnose due to often prolonging asymptomatic course until the infiltration of the adjacent structures occurs. Therefore, patients are diagnosed with advanced-stage disease, which negatively affects the treatment outcomes. A 60-year-old male was referred to our ward from an outpatient clinic. The patient presented with double vision, right-side lacrimation, and exophthalmos. He also reported significant weight loss: 15 kg in 2 months. Physical examination revealed achiness and edema of the right temporal area, and subconjunctival hemorrhage of the right eye, and surprisingly no anosmia, no nasal obstruction, and no head/neck lymphadenopathy were present. The histopathology examination identified diffuse large B-cell lymphoma (CD20+ CD3- p63- bcl-2+ CD23-/+ bcl-6+ CD 10- MUM1+ Tdt- CD38- cyclin D1- CD30- c-myc+). The patient was qualified for R-CHOP immunochemotherapy (rituximab, cyclophosphamide, and hydroxydaunorubicin hydrochloride), which was well tolerated. After 3 months of treatment, all of the symptoms reversed and a whole-body PET scan showed no abnormal metabolic activity.
first_indexed 2024-03-09T16:21:41Z
format Article
id doaj.art-61edcae41ac548b4883ce02307282773
institution Directory Open Access Journal
issn 2038-8330
language English
last_indexed 2024-03-09T16:21:41Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Hematology Reports
spelling doaj.art-61edcae41ac548b4883ce023072827732023-11-24T15:12:57ZengMDPI AGHematology Reports2038-83302022-10-0114430530910.3390/hematolrep14040044Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying CauseOlga Lesniewska-Skowerska0Joanna Symela-Kaspera1Lucyna Klimczak-Gołąb2Wojciech Smolka3Jaroslaw Markowski4Department of Laryngology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, PolandDepartment of Laryngology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, PolandDepartment of Laryngology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, PolandDepartment of Laryngology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, PolandDepartment of Laryngology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, PolandSinus tumors are arduous to diagnose due to often prolonging asymptomatic course until the infiltration of the adjacent structures occurs. Therefore, patients are diagnosed with advanced-stage disease, which negatively affects the treatment outcomes. A 60-year-old male was referred to our ward from an outpatient clinic. The patient presented with double vision, right-side lacrimation, and exophthalmos. He also reported significant weight loss: 15 kg in 2 months. Physical examination revealed achiness and edema of the right temporal area, and subconjunctival hemorrhage of the right eye, and surprisingly no anosmia, no nasal obstruction, and no head/neck lymphadenopathy were present. The histopathology examination identified diffuse large B-cell lymphoma (CD20+ CD3- p63- bcl-2+ CD23-/+ bcl-6+ CD 10- MUM1+ Tdt- CD38- cyclin D1- CD30- c-myc+). The patient was qualified for R-CHOP immunochemotherapy (rituximab, cyclophosphamide, and hydroxydaunorubicin hydrochloride), which was well tolerated. After 3 months of treatment, all of the symptoms reversed and a whole-body PET scan showed no abnormal metabolic activity.https://www.mdpi.com/2038-8330/14/4/44lympomasinusmaxillarytumor
spellingShingle Olga Lesniewska-Skowerska
Joanna Symela-Kaspera
Lucyna Klimczak-Gołąb
Wojciech Smolka
Jaroslaw Markowski
Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause
Hematology Reports
lympoma
sinus
maxillary
tumor
title Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause
title_full Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause
title_fullStr Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause
title_full_unstemmed Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause
title_short Immense Tumor of Maxillary Sinus with Exophthalmos—A Rare Underlying Cause
title_sort immense tumor of maxillary sinus with exophthalmos a rare underlying cause
topic lympoma
sinus
maxillary
tumor
url https://www.mdpi.com/2038-8330/14/4/44
work_keys_str_mv AT olgalesniewskaskowerska immensetumorofmaxillarysinuswithexophthalmosarareunderlyingcause
AT joannasymelakaspera immensetumorofmaxillarysinuswithexophthalmosarareunderlyingcause
AT lucynaklimczakgołab immensetumorofmaxillarysinuswithexophthalmosarareunderlyingcause
AT wojciechsmolka immensetumorofmaxillarysinuswithexophthalmosarareunderlyingcause
AT jaroslawmarkowski immensetumorofmaxillarysinuswithexophthalmosarareunderlyingcause